Nashik:“The latest GST revisions announced in the 56th Council meeting are a progressive step in making healthcare more accessible and affordable for patients across India. This will also help in promoting medical tourism to the country. The removal of GST on lifesaving cancer drugs and the reduction of tax to 5 per cent on essential medicines and medical devices will significantly ease the financial burden on families already fighting one of the toughest battles of their lives. Cancer care is not just about advanced treatment but also about ensuring equity and access. By lowering costs on critical drugs, diagnostic kits and surgical devices, the Government has given hope to millions, who often struggle to manage treatment expenses. At HCG Manavata Cancer Centre, we welcome this initiative, which aligns with our mission of providing world-class cancer care that is both advanced and affordable,” says Prof Dr Raj Nagarkar, Chief of Surgical Oncology & Robotic Services and Managing Director – KIMS Manavata Hospitals, HCG Manavata Cancer Centre and Six Sigma, Nashik.
